BDD will be at CPHI Japan

BDD are delighted to announce their attendance at CPHI Japan April 19th - 21st.

If you are interested in meeting with us please contact calum.stevens@bddpharma.com

Featured Posts

BDD Pharma secures license agreement with top pharma company for timed-release OralogiK™ technology

BDD Pharma secures license agreement with top pharma company for timed-release OralogiK™ technology

£2M backing from Archangels and SIB for
UK drug delivery company BDD

£2M backing from Archangels and SIB for UK drug delivery company BDD

Recent Posts

Investment to respond to growth in demand for integrated services at UK drug delivery company BDD.

Another success for BDD's patented OralogiK™ technology with positive clinical results for colon

BDD signs agreement with Innovation Pharmaceuticals for Advanced Oral Tablet Technology in Treating

In-vivo disintegration and absorption of two fast acting aspirin tablet formulations compared to ibu

Releasing The Potential: How Novel Drug Delivery Technologies Can Deliver Competitive Advantage In T

BDD appoints ex-AstraZeneca VP Joanne Kelley as non-executive director to the Board

BDD Pharma and Cingulate Therapeutics announce license agreement with OralogiK™ enabled triple pulse

BDD Pharma secures license agreement with top pharma company for timed-release OralogiK™ technology

BDD at 4th Annual Formulation & Drug Delivery Congress. 8-9th May - London.

£2M backing from Archangels and SIB for UK drug delivery company BDD

Archive

Follow Us